Maria Bennett Shares Insights from SPR/Medtronic Merger
Earlier this summer, Medtronic announced that it completed its acquisition of SPR Therapeutics, Inc., the Cleveland, OH manufacturer of peripheral nerve stimulation systems for treating pain. The acquisition is valued at $650 million. NBR editor James Cavuoto sat down with SPR founder and CEO Maria Bennett at the recent meeting of the American Society of Pain and Neuroscience in Miami.